|
|
||||||||
Papers In Press, published online ahead of print October 4, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Physiology and Pharmacology, Chang Gung University, Tao-Yuan 333
Corresponding Author: yhma{at}mail.cgu.edu.tw
20-hydroxyeicosatetraenoic acid (20-HETE), a P450 arachidonic acid metabolite, has been shown to modulate growth of vascular smooth muscle cells (VSMC). We asked whether 20-HETE modulates proliferation of R22D cell, a clonal VSMC from neonatal rats, via releasing TGF-ß. Incubation of R22D cells with 20-HETE for 24 hr attenuated [3H]-thymidine incorporation in a concentration-dependent manner without causing release of lactate dehydrogenase. 20-HETE also inhibited platelet-derived growth factor (PDGF)-induced [3H]-thymidine incorporation in R22D cells and human VSMC. At 5 µM, 20-HETE reduced [3H]-thymidine incorporation by 34 ± 6%; anti-TGF-ß neutralizing antibody, but not nonspecific IgG, completely reversed the attenuated [3H]-thymidine incorporation induced by 20-HETE. In addition, 20-HETE attenuated fetal bovine serum- and PDGF-induced expression of cyclin D1, a downstream effector of TGF-ß1, which was reversed by anti-TGF-ß antibody. Further studies demonstrated that 20-HETE may increase TGF-ß release to a level enough to inhibit [3H]-thymidine incorporation without altering steady state mRNA level of TGF-ß. Nevertheless, pretreatment of indomethacin (a cyclooxygenase inhibitor) or paxilline (a potassium channel inhibitor) did not affect the inhibitory effect on DNA synthesis induced by 20-HETE. These results first demonstrate a growth inhibitory effect induced by 20-HETE, which may be mediated by TGF-ß.
Revised on October 3, 2007
Accepted on October 3, 2007
20-HETE inhibits proliferation of vascular smooth muscle cells via transforming growth factor-beta
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. M. Guo, J. Sheng, G. M. Scicli, A. S. Arbab, N. L. Lehman, P. A. Edwards, J. R. Falck, R. J. Roman, and A. G. Scicli Expression of CYP4A1 in U251 Human Glioma Cell Induces Hyperproliferative Phenotype in Vitro and Rapidly Growing Tumors in Vivo J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 10 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Karcher, D. O. Bayles, J. P. Bannantine, D. C. Beitz, and J. R. Stabel Osteopontin: A Novel Cytokine Involved in the Regulation of Mycobacterium avium subspecies paratuberculosis Infection in Periparturient Dairy Cattle J Dairy Sci, August 1, 2008; 91(8): 3079 - 3091. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Biasi, C. Mascia, and G. Poli The contribution of animal fat oxidation products to colon carcinogenesis, through modulation of TGF-{beta}1 signaling Carcinogenesis, May 1, 2008; 29(5): 890 - 894. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |